diabetestalk.net

Medtronic India

Medtronic Turns Eye To India With New Board Member And $6 Million Grant

Medtronic Turns Eye To India With New Board Member And $6 Million Grant

Post a comment / Sep 24, 2012 at 3:03 PM Last year, Medtronic CEO Omar Ishrak described India as the biggest hole in Medtronics global operations. Last week, the medical device maker named Preetha Reddy, managing director of Apollo Hospitals Enterprise Ltd.,a division of Indias premier hospital chain Apollo Group, as a board member. That same Friday, Medtronic also showed that it wants to do more than just business in India by announcing that the company is providing a $6 million grant over five years to speed up programs designed to increase access to cardiovascular and diabetes care for Indian patients who cannot easily get the care they need. In announcing the grant , Medtronic said that cardiovascular disease kills three million in India annually while the country is host to 60 million diabetics, giving it the dubious honor of having the most diabetics of any other nation in the world. By focusing on diabetes and cardiovascular disease, we hope to strengthen overall health systems in order to expand access in underserved communities,said Dr. Jacob Gayle, executive director of the Medtronic Foundation and vice president, Medtronic Community Affairs, in a news release. Given both the need and opportunity in India, it was clear that we needed to ramp up our support to help those already working to improve care. While the move is clearly altruistic, the move will likely build relationships that are key to forwarding business interests in the region. Medtronic has said in the past that it hopes to build a research and development center in the populous Asian nation, and Ishrak has said he will hire more engineers in Asia. No updates on the R&D center were available at this time, however. Continue reading >>

Medtronic India: Further, But Nottogether?

Medtronic India: Further, But Nottogether?

Home / Medtronic India: Further, but nottogether? Medtronic India: Further, but nottogether? By Viveka Roychowdhury on May 10, 2017 From designing the worlds first wearable battery powered pacemaker in 1958, to the worlds smallest pill sized pacemaker, Medtronics credo has been Further, together. But against the backdrop of the governments firm stand to make healthcare more affordable, what will be Medtronic Indias strategy to remain commercially viable as well as provide patients access to the latest generation medical devices? From co-founder Earl Bakkens Minnesota garage in 1949, to 89 manufacturing facilities across the world, Medtronic today positions itself as the worlds largest stand alone medical technology company. FY2016 total revenues touched $28.8 billion, with the lions share (61 per cent) coming from the Americas, followed by Europe, Middle East and Africa (23 per cent), followed by Asia Pacific (11 per cent) and 5 per cent from Greater China. In terms of revenue mix across the companys four business divisions, in FY2016 the cardiac and vascular group led with 35 per cent ($10.2 billion), followed by the minimally invasive therapies (formerly Covidien) at 34 per cent ($9.6 billion), restorative therapies (25 per cent, $7.2 billion) and diabetes (six per cent, $1.8 billion). The Medtronic Medallion has three short directives inscribed on it: Alleviating pain, Restoring health, Extending life. The evolution of pacemakers is a good example of the transformation of medical devices, driven by patient need and made possible by continuous R&D. Medtronic co-founder Bakken is credited with the design of the worlds first wearable battery powered pacemaker way back in 1958. Six decades later, Medtronic makes the Micra Transcatheter Pacing System, implanted directly Continue reading >>

Working At Medtronic: 58 Reviews | Indeed.co.in

Working At Medtronic: 58 Reviews | Indeed.co.in

IT Support Analyst(Current Employee) Bangalore March 25, 2018 It was a pleasure worked for Medtronic and really loved the culture and the Enterprise environment and had a great chances to learn and experience different tools and technologies. It's overall a place to explore and imporvise oneself. Stable company with a great product range Area Manager(Current Employee) India February 15, 2018 Sales role in the company can be stressful with regular pressure to meet targets. Product range is good and respected by the doctors. Overall job security is good. IT Technologist(Current Employee) Bengaluru, Karnataka October 3, 2017 Working on delivering an SAP infrastructure; greenfield or brownfield projects. Monitoring and Support. Coming up with scripts or procedure to fix it permanently rather than manual work for it. Sr. Market Development Specialist(Current Employee) India September 25, 2017 Freedom to explore strategic initiatives, best part there is no hierarchy system and hence very jovial and friendly environment at work. I learned a lot at Medtronic right from patient first motto to managing profitability with the same motive. Its very tough to get into aspiring roles, Buttering manager is the only way to excel in this organization. Program Manager - R&D(Current Employee) Hyderabad, Telangana July 24, 2017 -Its very tough to get into aspiring roles -Buttering manager is the only way to excel in this organization -Talks so high about diversity but no reality on ground 8/10 work place . Good to work .Completely individual owned .no team bonding Territory Manager(Current Employee) Chennai, Tamil Nadu July 23, 2017 Good place to work .Management is huge ,less interaction with ground level . Working with whole heart taking responsibility can lead you for career growth . it Continue reading >>

Medtronic India Development Center, Bangalore

Medtronic India Development Center, Bangalore

Medtronic India Development Center,Bangalore Medtronic India Development Center, Bangalore Renal Care Solutions (RCS) business unit of Medtronic established Medtronic India Development Centre(MIDC) in Bangalore in 2013, to develop key aspects of the RCS product portfolio. One of the key projects is a portable hemodialysis system. It is specifically suited to address the barriers that prevent wider availability of therapy for patients with end-stage renal disease in emerging economies. This system will include features such as portability, reduced water consumption, and a state-of-the art graphical user interface. The new portable hemodialysis system offers a unique product offering that not only provides strong patient benefits but also helps significantly improve access to the hemodialysis solution to patients in key emerging markets like India. MIDC is a true symbol of Medtronics commitment to growth and service of patients in India. It currently houses 80 team members with interdisciplinary skills, including Software and Embedded Systems Development, Mechanical/Electronics/Chemical/Systems Engineering, Human Factors Engineering, Supplier Management, Quality/Reliability, Manufacturing Design Transfer and Configuration Management. With the focus on Meaningful Innovation, MIDC leads the way with innovative solutions and has multiple pending global design patents. If you are interested in working on exciting projects using latest technology for the benefit of kidney failure patients across the world, please check out our current openings in the Careers section. R&D center for front-end innovation and new product development 26,000 sq. ft. facility in Whitefield, Bangalore Capacity for 130 employees from interdisciplinary backgrounds State-of-the-art labs for Chemical an Continue reading >>

India Medtronic Pvt Ltd

India Medtronic Pvt Ltd

Ghatkopar Andheri Link Road, Andheri (E), Mumbai, Maharashtra Tell us what you need by filling in the form We are here to help! Save time and let us provide you Medtronic began its operations in India in the year 1979. With over 1100 employees, India Medtronic Pvt. Ltd. is a wholly-owned subsidiary of Medtronic Plc. It is headquartered at Solitaire Corporate Park in Mumbai and has its offices at Ahmedabad, Bangalore, Chennai, Cochin, Dhaka, Gurgaon, Hyderabad, Kolkata, New Delhi, Pune and Vadodara and Colombo. ONE COMPANY, ONE MISSIONWritten in 1960, our Mission dictates that our first and foremost priority is to contribute to human welfare. Over a half-century later, the Mission continues to serve as our ethical framework and inspirational goal for our employees around the world. It guides our day-to-day work and reminds us that our efforts are transforming the lives of millions of people each year.THE MEDTRONIC MISSIONTo contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life. To direct our growth in the areas of biomedical engineering where we display maximum strength and ability; to gather people and facilities that tend to augment these areas; to continuously build on these areas through education and knowledge assimilation; to avoid participation in areas where we cannot make unique and worthy contributions. (See Patients for more about our therapies.) To strive without reserve for the greatest possible reliability and quality in our products; to be the unsurpassed standard of comparison and to be recognized as a company of dedication, honesty, integrity, and service. (See Quality to learn more about our industry leadership Continue reading >>

Medtronic To Withdraw Latest Stents From India After Price Cap - Business Line

Medtronic To Withdraw Latest Stents From India After Price Cap - Business Line

Medtronic to withdraw latest stents from India after price cap Abbotts stent faces another storm, this time on safety After Abbott, another major multinational medical devices maker Medtronic has decided to withdraw its latest stents from India following drug price regulator NPPAs move to cap their prices. Besides, Boston Scientific has said it too may follow suit. We have submitted an application for withdrawal of Resolute Onyx under the provisions of Drug Price Control Order, Medtronic said in a statement. The company said it will continue to supply Resolute Onyx till we get the required permissions from the authorities. Our decision to withdraw or introduce products is made only after taking into consideration all guidelines and norms set by the government. Medtronic said it will continue to work towards increasing access of cardiovascular therapy to patients in India and cater to different needs of patients and physicians while providing them with a choice of clinicallyproven and globallycertified stents like Resolute and Resolute Integrity. Boston Scientific said while its other drug eluting stents will continue to be available it may take a decision to discontinue its next generation stents Synergy and Promous Premier. Since the Price control order in February 2017, Boston Scientific has been in a constant dialogue with the government bodies under various legal provisions. We have sought the possible reliefs available under the law and also submitted details on the superior clinical attributes of our stents Synergy and Promus Premier, a Boston Scientific India spokesperson said in a statement. Any decision to discontinue these next generation stents may be taken as a part of the corporate sustainability review, it added. The National Pharmaceutical Pricing Author Continue reading >>

Medtronic

Medtronic

Medtronic Public Limited Company is a medical device company. Its headquarters are in Dublin, Ireland.[1][3][4][5] Its operational headquarters are in Fridley, Minnesota.[1][6] Medtronic is among the world's largest medical equipment development companies.[7] In 2015, at the time of its acquisition of Covidien, its market capitalisation was about $100 billion.[8] Medtronic operates in more than 140 countries.[1] It employs over 85,000 people and has more than 53,000 patents.[9] History[edit] Early history[edit] Medtronic Operational Headquarters in Fridley, Minnesota, a suburb of Minneapolis. Medtronic was founded in 1949 in northeastern Minneapolis by Earl Bakken and his brother-in-law, Palmer Hermundslie, as a medical equipment repair shop.[10] Through his repair business, Bakken came to know C. Walton Lillehei, a doctor of heart surgery at the University of Minnesota Medical School. The deficiencies of the pacemakers of the day were made painfully obvious following a power outage over Halloween in 1957, which affected large sections of Minnesota and western Wisconsin.[11] A pacemaker-dependent paediatric patient of Lillehei died because of the blackout. The next day, Lillehei spoke with Bakken about developing some form of battery-powered pacemaker. Bakken modified a design for a transistorised metronome and created the first battery-powered external artificial pacemaker. Medtronic's old headquarters in St. Anthony, Minnesota The company expanded through the 1950s, mostly selling equipment built by other companies but also developing some custom-made devices. Bakken built a small pacemaker that could be strapped to the body and powered by batteries. Work in the new field later produced an implantable pacemaker in 1960. The company built headquarters in the Minneapoli Continue reading >>

Medtronic To Provide Ear Care To 10 Mn Poor

Medtronic To Provide Ear Care To 10 Mn Poor

Medtronic to provide ear care to 10 mn poor New Delhi Medical technology company Medtronic on Monday said it has committed itself to providing ear care to 10 million poor people in the country through its Indian subsidiary by 2025. India Medtronic Private Limited aims to provide quality ear care to 10 million people from the underserved community of India by 2025 through its innovative ear care programme called Shruti, the company said in a statement. According to the Indian Journal of Otology, almost 80 per cent of hearing loss is preventable, yet many individuals do not have the awareness, or access to quality, affordable ear care. There is about six per cent of Indias population that suffers from hearing disability who need urgent intervention. Shruti is a health system innovation from Medtronic and aligns with the governments vision of Make in India and Digital India, said India Medtronic Managing Director Madan Krishnan. The Medtronic ear screening kit is designed in Bengaluru and manufactured in Chennai, he said. The Shruti programme uses information technology to drive down the costs and expand last mile access to quality healthcare, added Krishnan. Medtronic launched Shruti in 2013 to provide low-cost ear care that includes awareness, screening, diagnosis and low-cost treatment to the underserved in urban settlements and rural areas. With its presence in 25 hospitals across 18 cities in India and in Dhaka, Bangladesh and with the network of community health workers, more than 390,000 people have been screened and more than 8,000 people have received treatment at reduced cost, the company said. In December 2017, BCtA (Business Call to Action), a United Nations Development Program (UNDP) initiative, studied the impact of the Shruti programme. Medtronic plans to u Continue reading >>

Medtronic To Reach 10 Million People In India For Ear Care

Medtronic To Reach 10 Million People In India For Ear Care

Medtronic to reach 10 million people in India for ear care More than 75 million people are estimated to have hearing disability in India. 75 % of these patients have associated hearing loss due to multiple barriers existing between the patient and point of careETHealthWorld | Updated: March 13, 2018, 13:28 IST According to the Indian Journal of Otology, almost 80 percent of hearing loss is preventable, yet many individuals dont have the awareness, or access to quality, affordable ear care. Delhi/Mumbai, India March 10, 2018 Medtronic plc (NYSE:MDT), through its wholly owned subsidiary India Medtronic Private Limited in India, announced today it aims to provide quality ear care to 10 million people from the underserved community of India by 2025 through its innovative ear care program called Shruti . According to the Indian Journal of Otology , almost 80 percent of hearing loss is preventable, yet many individuals dont have the awareness, or access to quality, affordable ear care. In December 2017, a case study on the patient impact of the Shruti program was published by BCtA (Business Call to Action) - a United Nations Development Program (UNDP) initiative. Recently, BCtA studied the impact of the Shruti program on a sample of over 400 patients to measure peoples awareness of hearing impairments and ear care; the prevalence and age distribution of disease; patients income levels; post-treatment rehabilitation and satisfaction levels. Medtronic plans to use this impact data on Shruti to assess and improve screening and treatment protocols, measure improvements in the lives of patients and forge better partnerships with health service providers. There is about six percent of Indias population that suffers from hearing disability who need urgent intervention. At Medtronic Continue reading >>

About Medtronic Indian Subcontinent | Medtronic

About Medtronic Indian Subcontinent | Medtronic

Medtronic began its operations in India in the year 1979. With over 1100 employees, India Medtronic Pvt. Ltd. is a wholly-owned subsidiary of Medtronic Plc. It is headquartered at Solitaire Corporate Park in Mumbai and has its offices at Ahmedabad, Bangalore, Chennai, Cochin, Dhaka, Gurgaon, Hyderabad, Kolkata, New Delhi, Pune and Vadodara and Colombo. Our businesses primarily fall into four groups: the Cardiac and Vascular Group (CVG), the Restorative Therapies Group (RTG), the Diabetes Group and the Minimally Invasive Therapies Group (MITG). The Cardiac and Vascular Group encompasses Cardiac Rhythm and Heart Failure (CRHF), Coronary, Structural Heart and Arterial and Peripheral Vascular businesses; the Restorative Therapies Group includes Spine and Biologics, Surgical Technologies, Neuromodulation and Neurovascular businesses; the Diabetes Group offers Insulin Pump Therapy and Continuous Glucose Monitoring Systems (CGMS) and the Minimally Invasive Therapies group comprises of Early Technologies, Advanced Surgical Technologies and General Surgical Products, and Medical Supplies, Respiratory and Monitoring Solutions, and Venous Solutions. India Medtronic has two Research and Development (R&D) centers, in Bangalore and Hyderabad respectively. The Medtronic India Development Centre (MIDC) the R&D facility at Bangalore develops the key aspects of Medtronics renal care solutions business and the Medtronic Engineering and Innovation Center (MEIC) at Hyderabad provides high quality, cost effective engineering services to Medtronics Minimally Invasive Therapies Group (MITG) businesses global and regional business units. Medtronics first IT Solutions Center in India, established in Bangalore in the year 2014, delivers innovative, strategic and cost-effective IT solutions and s Continue reading >>

Research And Development At India Medtronic

Research And Development At India Medtronic

Research and Development at India Medtronic Research and Development at India Medtronic Our commitment to address universal healthcare needs and improve clinical outcomes through meaningful innovation Research and Development (R&D) is aligned with our mission, focused on addressing universal healthcare needs, improving clinical outcomes, expanding global access to care and optimizing costs and efficiencies across the healthcare continuumthrough three core strategies: Therapy innovation, Globalization and Economic Value. Medtronic has been leveraging the unique strength of India beyond providing therapies to the patients in India. To take advantage of Indias strength with a large pool of qualified engineers, doctors with wide ranging patient pool experience & hospitals providing quality care, Medtronic established- Medtronic Engineering and Innovation Centre,Hyderabad(MEIC) a state of the art, IT-enabled, captive engineering R&D center in India. It provides high-quality, high-performance, cost-effective engineering services to Medtronics products and its global and regional business units, supporting their product development and other engineering functions. Medtronic India Development Centre, Bangalore (MIDC) -The center focuses on key product, design and development aspects of the Renal Care Solutions business, which is currently developing a new hemodialysis system. MIDC aims to address the barriers that prevent wider availability of therapy for patients with end stage renal disease in emerging countries such as India. Continue reading >>

Abbott Healthcare, Medtronic India May Move Nppa Again To Withdraw Stents

Abbott Healthcare, Medtronic India May Move Nppa Again To Withdraw Stents

LIC seeks govt nod to buy controlling stake in IDBI Bank Mumbai: Abbott Healthcare Pvt. Ltd and Medtronic India Pvt. Ltd are likely to refile their applications with the National Pharmaceutical Pricing Authority (NPPA) to withdraw certain high-end coronary stents from the Indian market which they claim have become commercially unviable after government slashed prices by up to 85% in February. In February, the NPPA capped the price of bare metal stents at Rs7,260 and that of all drug-eluting stents at Rs29,600. In April, the regulator said price of stents can be increased by around 2% after taking into account the wholesale price index. Last week, Abbott had sought permission to withdraw its Alpine drug-eluting stent and Absorb dissolving stent, while Medtronic had sought to withdraw its Onyx Zotarolimus eluting stents but the NPPA rejected both the applications. After stent price cut, govt in no hurry to cap prices of other medical devices: NPPA The NPPA has concluded that all generations of drug-eluting stents are the same and on that basis, we had submitted withdrawal applications for Alpine and Absorb because they are no longer commercially viable for us in India. We have committed to maintaining supplies of Alpine and Absorb until the government advises us to do so, as part of the application review process. We continue to engage with relevant stakeholders on the right time to file the requisite applications, per due process, an Abbott spokesperson said. Medtronics application for the withdrawal of Resolute Onyx was not accepted by the NPPA on the basis of incomplete paperwork. We intend to resubmit the application, and until it is re-submitted and approved we will continue to supply the Resolute Onyx stent in India. All decisions to withdraw or introduce products Continue reading >>

India Medtronic Pvt Ltd - Company Information

India Medtronic Pvt Ltd - Company Information

Reward & Recognition of India Medtronic Pvt Ltd At Applied Materials, diversity and inclusion are part of our DNA. We are celebrating our 50th corporate anniversary and 15th anniversary in India. The world-class talent we hire and nurture are key to our success. I believe the more inclusive we are as an organization, the newer ideas we can generate to propel our success and growth to new heights. "I have spent more than a decade at Applied Materials and held various roles in software product management, IT service managementand global IT program management. Applied has given me an opportunity to grow as an individual and provided me with a strong career path. The flexible work environment has helped me manage a challenging and rewarding career with my home life, and allowed me to contribute significantly to the industry and women forums at the national and international level.I am happy to have laid the foundation for the India chapter of our female employee resource group - Women's Professional Development Network - and serve as its leader forfive years. I am also very excited to be involved in the diversity journey of Applied Materials in India and look forward to even greater times ahead. "I joined Applied Materials in 2013 as a chemistry manager at our Mumbai Chemistry Center of Excellence. My responsibilities support the Office of the CTO. Working at Applied Materials has been an incredible journey and learning opportunity. I get to work on cutting-edge technology in a nurturing environment that allows me to be a part of the company's growth trajectory. My team is comprised of brilliant physicists, chemists, material scientists and engineers that are dedicated to pushing the boundaries of science to develop new technology innovations." Deputy Director of Engineeri Continue reading >>

Medtronic India: Latest News & Videos, Photos About Medtronic India | The Economic Times

Medtronic India: Latest News & Videos, Photos About Medtronic India | The Economic Times

NPPA not to stop withdrawal of stents from market The authority had asked the companies to consider options for price revision before deciding to withdraw their products from the market. Apax leads race for Rs 2,600 crore sutures deal Healthium Medtech is a manufacturer and exporter of absorbable and non-absorbable sutures, surgical mesh, gloves and surgical tapes in a market heavily dominated by MNCs. Big US companies like Boeing, Pratt & Whitney head to Uttar Pradesh to meet Yogi Adityanath next week Officials from the US Embassy and US Trade and Development Agency will also be a part of the delegation led by the Boeing India President Pratyush Kumar. Local stent companies catch fancy of PE players As multinational stent makers ponder their prospects in India after price controls introduced this year, their local rivals have popped up on the radar of private equity investors. 'US in UP': Big American firms to meet CM Adityanath tomorrow The delegation will visit the state under the aegis of US-India Strategic Partnership Forum (USISPF), Singh, who is UP Health Minister. Yogi Adityanath to visit US in May, sell UP as investment destination The CM could visit Silicon Valley along with half a dozen American cities, hold roadshows and meet nonresident Indians from Uttar Pradesh and Bihar during the trip. Angioplasty cost falls up to 18 per cent on stent price cap Angioplasty cost at corporate hospital chains came down by 8-12% to 2.05 lakh-2.20 lakh from 2.10 lakh-2.20 lakh, the study showed. Addition of stents to essential list contrary to international norms, says US embassy official. Medical devices firm Medtronic to provide relief to US patients The company plans to offer high priced devices like stents, heart valves and pacemakers on monthly instalments to low-incom Continue reading >>

India Medtronic Pvt Ltd In Chakala-andheri East, Mumbai

India Medtronic Pvt Ltd In Chakala-andheri East, Mumbai

India Medtronic Pvt Ltd in Chakala-Andheri East, Mumbai India Medtronic Pvt Ltd in Mumbai. Surgical Equipment Dealers with Address, Contact Number, Photos, Maps. View India Medtronic Pvt Ltd, Mumbai on Justdial. Dealers of surgical equipment, India Medtronic Pvt Ltd in Chakala-Andheri East, Mumbai is one among the acknowledged and leading distributors, stockists, and suppliers in the city. This enterprise has made conscientious strides to offer top-notch and best-in-class products to their clients each time. Over time, it has made an indelible mark in the healthcare industry. One can choose from a diverse and comprehensive product range of surgical, medical, hospital and mobility equipments. Certified by relevant quality standards, the products carry a high degree of precision, attributing a certain degree of reliability. This enterprise is also an authorised service provider for surgical and mobility equipments. Locate this establishment with ease at 12/14, Building No 12, 4th Floor, Andheri Ghatkopar Road. Undoubtedly it is one of the best surgical equipment dealers in Chakala-Andheri East, Mumbai. Products and Services offered at India Medtronic Pvt Ltd India Medtronic Pvt Ltd in Chakala-Andheri East showcases a vast product range, including wheel chairs, digital meters, surgical instruments, blood pressure monitors, glucose meter, water and air bed, nebulizer, adult diapers, water and air bed, under pad, orthopaedic supports like sacro lumbar belt, abdominal belt, knee support, ankle binder and waist belt, digital thermometers, Littmann stethoscopes, hot water bag, orthopaedic heating pad, composition monitors, orthopedic heating pad, morning walker, pill boxes, yoga mats, gel pack, hot and cold gel packs, compression stockings, arm sleeves, sphygmomanometer, and m Continue reading >>

More in diabetes